Brief: Dermapharm Acquisition Of C³ Cannabinoid Compound Company GmbH

Dermapharm Holding SE

15/12/2021 12:47

Dec 15 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * ACQUISITION OF  C³ CANNABINOID COMPOUND COMPANY GMBH
    * DEPURCHASE PRICE IS IN ORDER OF EUR 80 MILLION PLUS
POSSIBLE
PERFORMANCE-BASED LIMITED PURCHASE PRICE COMPONENTS
    * ENTERED INTO AN AGREEMENT WITH CANOPY GROWTH GERMANY GMBH,
BASED
IN ST. LEON-ROT, GERMANY, TO ACQUIRE C³ CANNABINOID COMPOUND
GMBH, BASED IN NEUMARKT, GERMANY
    * AND ITS SUBSIDIARIES SPECTRUM THERAPEUTICS GMBH, BASED IN
NEUMARKT, GERMANY, THC PHARM GMBH HEALTH CONCEPT, BASED IN
FRANKFURT, GERMANY, AND SPECTRUM THERAPEUTICS AUSTRIA GMBH,
BASED IN VIENNA, AUSTRIA
    * CLOSING OF TRANSACTION IS SUBJECT TO APPROVAL OF ANTITRUST
AUTHORITIES
    * MANAGEMENT BOARD EXPECTS TRANSACTION TO BE COMPLETED BY
END OF
JANUARY 2022

Source text for Eikon:  ID:nEQ7nvXkWa 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))